Invasive BCI

Peking University Third Hospital, a top-tier (Grade 3A) general hospital in Beijing whose neurosurgery department is one of its key specialties, is taking part in a clinical trial of a Chinese-developed invasive brain-computer interface (BCI), neurosurgeons Yang Jun and Yu Tao wrote in the 16th issue of China Hospital CEO magazine. The trial enrolls patients with spinal cord injury and relies on a multidisciplinary team (MDT) to restore hand function after implantation. Invasive BCIs read neural signals through electrodes placed inside the skull or on the cortical surface, so surgery and rehabilitation depend on close coordination among neurosurgery, rehabilitation and imaging departments. The disclosure marks one step in Chinese hospitals' clinical validation of domestic systems. Public information has not named the system or disclosed enrollment, follow-up milestones or primary endpoints, and no efficacy or safety data have been released.

Shanghai-based StairMed has taken its wireless implantable brain-computer interface system into human evaluation for people with speech impairments. The prospective, single-arm trial (NCT07647315) actually began on September 1, 2026, is now recruiting, and plans to enroll 4 participants. Subjects will undergo surgical implantation and brain-control training, followed by an expected 12 months of follow-up recording adverse events, serious adverse events and device deficiencies, along with efficacy data on brain-controlled interaction and communication. Primary completion is expected on August 30, 2028, and the study as a whole on December 30, 2028. The registry record does not disclose the implant site, decoding method or detailed eligibility criteria, and no interim results have been posted, so conclusions on safety and efficacy will have to wait for follow-up data.

Neuracle Medical Technology (Shanghai) Co., Ltd. has registered a cortical electrode, model 1014-35, in the medical device unique identification (UDI) database of China's National Medical Products Administration (NMPA), under registration certificate Guoxiezhuzhun 20263120536. Neuracle's product line spans EEG acquisition equipment and implantable electrodes. The electrode belongs to an implantable EEG electrode kit (cortical electrode, blank electrode, electrode dilator, tunneler, torque wrench, lead fixation clip, fixation screws and electrode protective sleeve) that holds its own registration certificate and is also a component of an implantable BCI hand motor function compensation system. That system comprises a BCI implant, the electrode kit, an EEG signal transceiver, a pneumatic glove, a single-use surgical toolkit, and three software packages for EEG decoding, medical testing and clinical management.

Researchers recorded passengers' EEG as they watched driving scenes in a highly automated vehicle, then trained models to judge whether a risk lay ahead and where the hazard appeared. A 3D-CRNN reached 95.3% ± 2.7% balanced accuracy in risk prediction and raised hazard identification from 80.9% to 85.0%. In cross-subject tests on passengers the model had not seen, balanced accuracy fell to 64.9% ± 8.5%, showing the approach is still some way from deployment.

Researchers at the University of California, San Francisco (UCSF), a public research university known for its neuroscience work, had two Parkinson's disease patients train at home with a brain-computer interface (BCI) airplane-simulator game, learning to down-regulate cortical beta activity and thereby control the intensity of their own deep brain stimulation (DBS). The work, posted as a preprint on medRxiv on August 17, 2026, points to BCI applications in neuromodulation and to more personalized treatment for Parkinson's and other conditions; its conclusions have not yet been peer reviewed.

To move from lab prototypes to long-term clinical systems, implantable brain-computer interfaces must place thousands to millions of electrodes several millimeters to centimeters deep in brain tissue without heating it by more than about 1 degree Celsius. This review benchmarks inductive, mid-field, RF, ultrasonic, magnetoelectric, optical, UWB and electro-quasistatic wireless links against three clinical axes (depth, size and data rate), noting that almost every clinically relevant implant is weakly coupled, with coupling coefficients of only 10^-3 to 10^-1. Within a communication budget of about 10 mW, narrowband high-Q links suit power transfer and low-speed data, but at 1-10 nJ/b they cannot deliver the more than 10 Mbps to tens of Gbps uplinks that interfaces with a thousand or more channels require. The study is a preprint and has not been peer reviewed.

Endovascular EEG recorded approximately 3.7 times the power of concurrent scalp EEG in 5 patients undergoing an intracarotid amobarbital injection, known as the Wada test, and the nearest endovascular-scalp electrode pairs showed consistently higher coupling in every participant, a mean difference of 4.9 percentage points ranging from 1.8% to 7.6% across individuals and most pronounced at separations under 30 mm. Endovascular EEG has emerged as a brain monitoring technique that balances signal fidelity against invasiveness, the authors write, matching subdural recordings in bandwidth and signal-to-noise ratio in animal studies, but its signal properties have been sparsely quantified in people. All signals were preprocessed with artifact rejection and independent component analysis, then assessed with power spectral density, imaginary coherence, phase-locking value and amplitude envelope correlation.

Spatial-covariance EEG features can flag whether an operator's decision will be correct before the response is committed, and weighting group votes by that signal raised accuracy on contested trials from 57% to 88% as team size grew from 2 to 16, according to a preprint. Twenty-three participants ran a virtual reality target-detection task under high and low cognitive workload, and the gain appeared only in the high-workload condition; under low workload the weighting hurt performance. EEG-based decision-reliability signals are therefore workload-conditional rather than a general-purpose team augmentation tool, the authors write; the preprint has not been peer reviewed.

Researchers at the Technical Institute of Physics and Chemistry of the Chinese Academy of Sciences and collaborating institutions have developed a neural electrode interface that, they report, significantly extended electrode operational lifetime and improved signal fidelity over six months of in vivo implantation. The material, a benzyloxycarbonyl-substituted poly(ornithine-alt-glycine) coating abbreviated OGCbz, resists biofouling and immunogenic rejection without degrading electrical performance, targeting what the authors call the critical obstacle to electrodes that combine long-term recording with tunable biofunctional control: an immune-mediated foreign body response in which glial scar encapsulates implants like cement. Substituting the Cbz group with other functional moieties preserves those antifouling and biocompatibility properties while adding new ones, and as a proof of concept the peptide sequence IKVAV and the antibody cetuximab gave the interface neuron affinity and tumor cell proliferation inhibition respectively; the six-month result came from the IKVAV-functionalized version.

Implantable brain-computer interfaces are shifting from rigid silicon architectures to soft, structurally adaptive systems built for seamless, long-term integration with neural tissue, according to a review of flexible electrode materials and structural design published in SmartMat on August 31, 2026. Breakthroughs in materials science and micro/nanofabrication have given this generation of devices mechanical compliance, robust interfacial adhesion and high-fidelity signal acquisition that earlier designs could not reach, the review says. Long-term stability at the electrode-tissue interface remains one of the core bottlenecks for invasive BCI.

Researchers report that more than 150 children worldwide have received implanted brain-computer interfaces, a number expected to grow quickly as the devices reach the market. A 2026 paper in Neurorehabilitation and Neural Repair spells out a roadmap for pediatric iBCI development, including work from the first International Virtual Summit on Implanted BCIs for Children with Complex Needs and workshops at the 11th International BCI Society Meeting. It highlights unresolved questions about early-life implantation and pediatric indications that must be answered before the technology is deployed widely in children.

Researchers at the University of Colorado Boulder have built ERP-XTTN, a cross-attention model that classifies event-related potentials (ERPs) in users it has never seen, with no per-user calibration. Across three public datasets and eight ERP components, it trailed the best baseline by 0.025 AUROC on average using only three channels. The work appeared in the Journal of Neural Engineering.

Researchers at the Second Affiliated Hospital of Xi'an Jiaotong University in northwestern China and the Key Laboratory of Biomedical Information Engineering of the Ministry of Education have built an in vitro screening platform combining electrospun PLCL with inkjet-printed reduced graphene oxide (rGO) and growth-factor micropatterns. Because it varies conductive, biochemical and topographical cues together, the platform can evaluate printing parameters and electric-field strength in a single system. Under 150 mV/cm direct-current stimulation, PC-12 cells showed more neurite-like outgrowth and better alignment than with no stimulation or at 300 mV/cm.

A team at Kunming University of Science and Technology, in southwestern China's Yunnan province, has published a paper in the Journal of Biomedical Engineering analyzing how inherent limitations set the capability boundaries of brain-computer interfaces (BCIs). Dynamic neural coding, inter-individual variability, low signal-to-noise ratio, partial observability and paradigm dependence jointly impose upper limits on decoding accuracy, information transfer rate, complex intention decoding, user experience and system stability. The authors propose information enhancement, adaptive decoding, human-machine collaboration and system optimization, arguing that gains will come from extracting more from the neural signal rather than from overcoming the underlying limits.

A workshop at the BCI Society Meeting 2025, run with the Implantable BCI Collaborative Community (iBCI-CC), took up how clinical outcome assessments (COAs) for pivotal BCI trials should be selected, developed and validated. Participants pointed to patient heterogeneity, the absence of widely validated COAs, and the difficulty of capturing outcomes that matter in home and daily-life settings. The discussion lays groundwork for the iBCI-CC Clinical Study Endpoints Workgroup to build a transparent process for identifying meaningful aspects of health and concepts of interest, in support of regulatory approval and reimbursement.

BCIFlex Medical Technology has begun a clinical trial in China evaluating the safety and efficacy of an implantable wireless brain-computer interface in patients left tetraplegic by spinal cord injury. The trial is registered on ClinicalTrials.gov as NCT07784088 and is recruiting. The sponsor is a Chinese device maker headquartered in the Haidian district of Beijing with an office in Shanghai, working on invasive ultra-thin flexible electrodes; its products include digital EEG systems and stereo-EEG depth electrodes.

Thirty-eight typically developing children aged 8 to 12 used a design application to build their own picture-based interface for a P300 brain-computer interface augmentative and alternative communication (P300-BCI-AAC) system, in a study of what children themselves want from such interfaces. They consistently chose preferred colors, animation — zooming most of all — and sound cues: animation aided visual accessibility and target location, background color changes carried preferred colors into the display, and video GIFs and picture overlays added personal relevance. The authors call motion, color, personalization and visual clarity preliminary priorities for pediatric BCI-AAC design, and point to follow-up work with children who use AAC daily and with people who have motor difficulties.

A preprint bolts parameterized quantum circuits onto a ResNet-50 backbone as residual sidecar modules and tests them on 31-class decoding of neural population activity from imagined handwriting. The backbone-gradient variant improved accuracy in three of four seeds and consistently lowered linear CKA similarity to the baseline features, which the authors read as a structural reorganization of the learned representation. They claim no quantum advantage.

A review published on August 20, 2026 in npj Biomedical Innovations proposes brain-inspired brain-computer interfaces (BI-BCIs), a framework that unifies neuromorphic computing with BCI design to make neurotechnology lower-power, smaller and capable of closed-loop operation. The authors, from Aarhus University, Stanford University, the University of Southern Denmark, the University of Genoa, Forschungszentrum Jülich and RWTH Aachen University, say the approach could advance neuroprosthetics and neuromodulation for neurological disorders.

A Stanford program is recording brain activity in psychiatric inpatients at millisecond precision, combining noninvasive electrode arrays with deep brain recording electrodes to trace the circuits behind schizoaffective disorder, borderline personality disorder, autism and cancer-induced depression. The Human Neural Circuitry program, led by neuroscientist Karl Deisseroth at the Wu Tsai Neurosciences Institute, has run for three years and moves data over fiber-optic and copper links fast enough for round trips of under half a millisecond, allowing the system to sense and respond in a closed loop. Deisseroth said the key innovation is getting results at millisecond precision, which he called a crucial step toward understanding complex psychiatric symptoms.